Pilot Study of Spinal Manipulation for Chronic Neck Pain

This study has been terminated.
Sponsor:
Information provided by:
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT00030004
First received: January 29, 2002
Last updated: August 17, 2006
Last verified: July 2006
  Purpose

This study is designed to determine whether a medicine that can produce temporary amnesia (midazolam) can be used to block the memory of treatment with spinal manipulation. This is important since any study that is designed to determine whether spinal manipulation is effective would be better if patients were not aware of whether or not they were treated. This would allow a true assessment of treatment effects without the complication of a strong placebo effect that manipulative treatment may produce.


Condition Intervention Phase
Neck Pain
Procedure: spinal manipulation
Drug: midazolam
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Pilot Study of Spinal Manipulation for Chronic Neck Pain

Resource links provided by NLM:


Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment: 30
Study Start Date: May 2000
Estimated Study Completion Date: April 2001
Detailed Description:

There has been growing recognition of the high frequency with which Americans utilize complementary and alternative health care providers and that annually about 10% of the population is treated by a chiropractor. While chiropractors employ several types of treatment, spinal manipulation is the most important and unique of these therapies. Over 90% of the spinal manipulations performed in the U.S. are done by chiropractors with most of the remainder performed by osteopathic physicians. The annual number of chiropractic visits in the U.S. has been estimated at approximately 100 per 100 person-years.

Spinal manipulation and chiropractic have been controversial at least partially due to a paucity of clinical scientific evidence of benefit. For example, reviews of the literature on randomized clinical trials (RCT's) of manipulative treatment for back pain have variably found evidence of benefit or insufficient evidence of benefit. A review of the existing clinical trials of spinal manipulation for neck pain concluded that most of the five existing RCT's were of relatively poor quality and that, despite some evidence for very short-term benefit, studies of higher quality will be needed in order to determine whether there is clinical benefit for this condition. This issue is important since neck pain is the second most common reason for presentation to chiropractors.

There are several difficulties in researching the effects of spinal manipulation. Most of the conditions that are treated (i.e., back and neck pain) do not have a well-defined pathophysiology. Therefore, it is not possible to study treatment by evaluating the effects of treatment on physiological variables. The lack of a proven pathophysiology also leads to heterogeneous study populations with large variability in response to treatment. This makes it necessary to use large experimental populations in order to detect any effects of treatment. There is heavy reliance on subjective outcome measures in neck and back pain research, making these clinical trials particularly sensitive to placebo or "nonspecific" effects. The use of blinded subjects is the accepted method of dealing with these issues, but blinding is particularly difficult to achieve when investigating physical interventions, particularly those where the therapist can't be blinded as to whether s/he is delivering an actual or sham treatment.

The present proposal is in response to a request for applications for pilot studies to establish the methodological feasibility and strengthen the scientific rationale for proceeding to full-scale RCTs on the use of chiropractic or osteopathy to manage or treat musculoskeletal injuries and disorders. One of the stated goals of this request for applications is to refine the control strategy for studies of manipulative therapy. The proposed study will examine whether an amnestic agent, midazolam, can be used to blind subjects to their experimental group in a double-blind, pilot RCT. This proposal is similar to a study by Sloop et al who used diazepam to produce amnesia in a study of spinal manipulation for chronic neck pain. The present study will utilize an agent with more specific amnestic effects and will also address several methodological problems with their study. If successful, the methods employed in this pilot study may permit a high degree of blinding in full scale RCT's of spinal manipulation.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

This study will enroll patients with chronic neck pain (more than 3 months duration) with or without occipitally-based head pain and without signs of radiculopathy or myelopathy. They must have pain of at least moderate intensity (by their report and by a score of at least 3 out of 10 on a visual analogue pain scale) on at least four days out of a week and have had some limitations of activity on a weekly basis due to their neck pain. These subjects should not have had spinal manipulative treatment for at least two years and should not have had any adverse reactions to manipulative treatment or to benzodiazepines. They may not be regular users of benzodiazepine medications. They also should not be currently enrolled in an ongoing physical therapy program, though they may be taking analgesics, anti-inflammatories or other medications for their problem. They may continue with any ongoing exercise program. Subjects will also be excluded if they are pregnant, lactating or plan to be pregnant, if they have significant cardiac or pulmonary disease or if they plan on relocating during the course of the study. The subjects will also be evaluated by a trained and experienced manipulative practitioner (see below) for the presence of lesions which would be amenable to manipulation and by a medical physician for the absence of any contraindications to manipulative treatments.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00030004

Locations
United States, New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03766
Sponsors and Collaborators
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00030004     History of Changes
Obsolete Identifiers: NCT00029705
Other Study ID Numbers: R01 AT000121-01
Study First Received: January 29, 2002
Last Updated: August 17, 2006
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Neck Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on September 16, 2014